{"schema_version":"1","generated_at":"2026-10-29T02:13:16.009Z","data_as_of":null,"url":"https://www.findmykol.com/kol/catherine-albert","json_url":"https://www.findmykol.com/kol/catherine-albert/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"catherine-albert","name":"Catherine Albert","credential":"MD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Seattle Children's Hospital","institution_url":"https://www.findmykol.com/institution/seattle-children-s-hospital","city":"Seattle","state":"WA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1740454362","orcid":"0000-0001-7610-9932","openalex":"A5037880995"},"summary":"Catherine Albert is an Oncology physician affiliated with Seattle Children's Hospital. OpenAlex indexes 62 publications with 1,322 citations (h-index 13); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":62,"cited_by_count":1322,"h_index":13,"latest_activity_year":2026,"source":"works"},"trials":{"count":2,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05312411","title":"A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma","phase":"PHASE1","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"Seattle Children's Hospital","source_url":"https://clinicaltrials.gov/study/NCT05312411","trial_url":"https://www.findmykol.com/trial/NCT05312411"},{"nct":"NCT04483778","title":"B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults","phase":"PHASE1","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"Seattle Children's Hospital","source_url":"https://clinicaltrials.gov/study/NCT04483778","trial_url":"https://www.findmykol.com/trial/NCT04483778"},{"nct":"NCT02311621","title":"Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01","phase":"PHASE1","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"Seattle Children's Hospital","source_url":"https://clinicaltrials.gov/study/NCT02311621","trial_url":"https://www.findmykol.com/trial/NCT02311621"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Aadi Bioscience, Inc.","program_year":2025,"amount_usd":127.12,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1740454362"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1740454362","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"The First-in-Human ENCIT01 Trial Comparing Second- versus Third-Generation L1CAM-specific CAR T Cells in Patients with Primary Refractory or Relapsed Neuroblastoma","year":2026,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1078-0432.ccr-26-0009","status":"verified"},{"title":"Abstract A029: Larotrectinib long-term efficacy and safety in pediatric patients with TRK fusion non-primary CNS tumors: Analysis update","year":2026,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.fusionpositive26-a029","status":"verified"},{"title":"Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial","year":2025,"journal":"Nature Medicine","source_url":"https://doi.org/10.1038/s41591-024-03451-3","status":"verified"},{"title":"Locoregional infusion of EGFR806-CAR T cells for recurrent or refractory pediatric CNS tumors: Results of the completed BrainChild02 phase 1 clinical trial","year":2025,"journal":"Neuro-Oncology","source_url":"https://doi.org/10.1093/neuonc/noaf064","status":"verified"},{"title":"Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.24.00848","status":"verified"}],"source":"works"},"contact":{"address_1":"4800 SAND POINT WAY","address_2":"M/S MB 8.501","city":"Seattle","state":"WA","zip":"98105","phone":"206-987-2106","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1740454362","source":"identity"},"similar":[{"name":"Margaret Rosenfeld","slug":"margaret-rosenfeld","institution":"Seattle Children's Hospital","specialty":"Pediatric Pulmonology","url":"https://www.findmykol.com/kol/margaret-rosenfeld","json_url":"https://www.findmykol.com/kol/margaret-rosenfeld/profile.json"},{"name":"Douglas Hawkins","slug":"douglas-hawkins","institution":"Seattle Children's Hospital","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/douglas-hawkins","json_url":"https://www.findmykol.com/kol/douglas-hawkins/profile.json"},{"name":"Michael Portman","slug":"michael-portman","institution":"Seattle Children's Hospital","specialty":"Pediatric Cardiology","url":"https://www.findmykol.com/kol/michael-portman","json_url":"https://www.findmykol.com/kol/michael-portman/profile.json"},{"name":"Nicholas Kassebaum","slug":"nicholas-kassebaum","institution":"Seattle Children's Hospital","specialty":"Anesthesiology","url":"https://www.findmykol.com/kol/nicholas-kassebaum","json_url":"https://www.findmykol.com/kol/nicholas-kassebaum/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2016-07-21","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}